首页> 外文期刊>American Journal of Pathology >A Cell Culture System for the Study of Amyloid Pathogenesis : Amyloid Formation by Peritoneal Macrophages Cultured withRecombinant Serum Amyloid A
【24h】

A Cell Culture System for the Study of Amyloid Pathogenesis : Amyloid Formation by Peritoneal Macrophages Cultured withRecombinant Serum Amyloid A

机译:研究淀粉样蛋白发病机理的细胞培养系统:通过重组血清淀粉样蛋白A培养的腹膜巨噬细胞形成淀粉样蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

A murine macrophage culture system that is both easy to employ and amenable to manipulation has been developed to study the cellular processes involved in AA amyloid formation. Amyloid deposition, as identified by Congo red-positive, green birefringent material, is achieved by providing cultures with recombinant serum amyloid A2 (rSAA2), a defined, readily produced, and highly amyloidogenic protein. In contrast to fibril formation, which can occur in vitro with very high concentrations of SAA and low pH, amyloid deposition in culture is dependent on metabolically active macrophages maintained in neutral pH medium containing rSAA2 at a concentration typical of that seen in acute phase serum. Although amyloid-enhancing factor is not required, its addition to culture medium results in larger and more numerous amyloid deposits. Amyloid formation in culture is accompanied by C-terminal processing of SAA and the generation of an 8.5-kd fragment analogous to amyloid A protein produced in vivo. Consistent with the possibility that impaired catabolism of SAA plays a role in AA amyloid pathogenesis, treatment of macrophages with pepstatin, an aspartic protease inhibitor, results in increased amyloid deposition. Finally, the amyloidogenicity exhibited by SAA proteins in macrophage cultures parallels that seen in vivo, eg, SAA2 is highly amyloidogenic, whereas CE/J SAA is nonamyloidogenic. The macrophage culture model presented here offers a new approach to the study of AA amyloid pathogenesis.
机译:已经开发出易于使用且易于操作的鼠类巨噬细胞培养系统,以研究参与AA淀粉样蛋白形成的 细胞过程。刚果红阳性绿色双折射材料确定的淀粉样 沉积是通过向培养物中提供重组血清淀粉样蛋白 A2(rSAA2)来实现的,一种确定的,易于生产的,高度淀粉样蛋白 蛋白质。与原纤维形成相反,原纤维形成可能发生在具有高浓度SAA和低pH值的 体外,培养物中淀粉样蛋白 的沉积取决于代谢活性巨噬细胞 保持在含有rSAA2的中性pH介质中,其浓度 是急性期血清中的典型浓度。尽管不需要淀粉样增强因子,但将其添加到培养基中会导致更大,数量更多的淀粉样沉积物。培养物中淀粉样蛋白形成 伴随着SAA的C末端加工,并且 产生了一个8.5 kd的片段,该片段类似于淀粉样蛋白A 体内。与SAA的 分解代谢在AA淀粉样蛋白发病中起作用,天冬氨酸蛋白酶抑制剂pepstatin治疗巨噬细胞的可能性相符的结果与以下结果一致: 淀粉样蛋白沉积增加。最后,巨噬细胞培养物中SAA蛋白表现出的淀粉样原性 与体内观察到的相似,例如SAA2具有高度淀粉样原性,而CE / J SAA不致淀粉样。 此处提出的巨噬细胞培养模型为研究AA淀粉样蛋白的发病机理提供了一种新方法。

著录项

  • 来源
    《American Journal of Pathology》 |1999年第1期|123-133|共11页
  • 作者单位

    From the Department of Medical and Molecular Genetics,Indianapolis, Indiana;

    From the Department of Medical and Molecular Genetics,Indianapolis, Indiana;

    From the Department of Medical and Molecular Genetics,Indianapolis, Indiana;

    From the Department of Medical and Molecular Genetics,Indianapolis, Indiana|Indiana University School of Medicine, and Richard L. Roudebush Veterans Affairs Medical Center,Indianapolis, Indiana;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号